Provides the 2019 AHA/ACC/HRS focused update on guidelines for managing atrial fibrillation.
Updates adult congenital heart disease management standards; reinforces consensus from Level 1 evidence for clinicians and researchers.
Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair [#][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Joshua A. Beckman, MD, MS, FAHA Kim K. Birtcher, PharmD, MS, AACC Biykem Bozkurt, MD, PhD, FACC,
No takes yet. Share an insight, caveat, or question.
January et al. (2019) studied this question. The 2019 AHA/ACC/HRS focused update provides revised clinical guidelines and recommendations for the management of patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: